🇺🇸 FDA
Patent

US 6127372

Sulfonamide inhibitors of aspartyl protease

expired A61PA61P31/12A61P43/00

Quick answer

US patent 6127372 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P31/12, A61P43/00